L04AC01 Daclizumab
ATC class of level 5 – chemical substance
This page lists the patient medication information or the product monograph for 3 drugs in this drug class.
- 3 prescription (Rx)
Place in the ATC system
- L Antineoplastic and immunomodulating agents 1,069 drugs
- L04 Immunosuppressants 246 drugs
- L04A Immunosuppressants 246 drugs
- L04AC Interleukin inhibitors 26 drugs
- L04AC01 Daclizumab 3 drugs
- L04AC Interleukin inhibitors 26 drugs
- L04A Immunosuppressants 246 drugs
- L04 Immunosuppressants 246 drugs
Active ingredients of the class
- Daclizumab 1 drug
- Daclizumab beta 2 drugs
Drugs in the class
| Drug | Rx or OTC |
|---|---|
| Zenapax 5mg/mL PM | prescription (Rx) |
| Zinbryta (Biogen Canada, PM 00044107) | prescription (Rx) |
| Zinbryta (Biogen Canada, PM 00048279) PM | prescription (Rx) |
Other classes of the same level
- L04AC02 Basiliximab 1 drug
- L04AC03 Anakinra 1 drug
- L04AC05 Ustekinumab 4 drugs
- L04AC07 Tocilizumab 3 drugs
- L04AC08 Canakinumab 2 drugs
- L04AC11 Siltuximab 1 drug
- L04AC12 Brodalumab 1 drug
- L04AC13 Ixekizumab 1 drug
- L04AC14 Sarilumab 2 drugs
- L04AC16 Guselkumab 1 drug
- L04AC17 Tildrakizumab 1 drug
- L04AC19 Satralizumab 1 drug
- L04AC21 Bimekizumab 1 drug
- L04AC22 Spesolimab 1 drug
- L04AC24 Mirikizumab 2 drugs
Other names of the drug class
- English (United Kingdom): L04AC01 daclizumab
- German: L04AC01 Daclizumab
- German (Austria): L04AC01 Daclizumab
- Italian: L04AC01 DACLIZUMAB
- Turkish: L04AC01 daklizumab
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class L04AC01
Ask your doctor or pharmacist for advice.